Vitamin D Supplementation in Adolescents and Young Adults with Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial

Arthritis Care and Research

Volumn 68, Issue 1, 2016, Pages 91-98

  Lima, Glauce L ^a   Paupitz, Juliane ^a   Aikawa, Nadia E ^a   Takayama, Liliam ^a   Bonfa, Eloisa ^a   Pereira, Rosa M R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; AZATHIOPRINE; COLECALCIFEROL; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISONE; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; VITAMIN; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSESSMENT; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; DRUG USE; EPIGASTRIC PAIN; EUROPEAN CONSENSUS LUPUS ACTIVITY MEASUREMENT; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HUMAN; KIDS FATIGUE SEVERITY SCALE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SLEDAI; SOCIAL LIFE; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGE; ANALOGS AND DERIVATIVES; BLOOD; BRAZIL; DIETARY SUPPLEMENT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PSYCHOLOGY; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; BIOMARKERS; BRAZIL; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMINS; YOUNG ADULT;

EID: 84956646097     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22621     Document Type: Article

References (48)

1. DeLuca HF., Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80: 1689-96.
2. De Borst MH, de Boer RA, Stolk RP, Slaets JP, Wolffenbuttel BH, Navis G., Vitamin D deficiency: universal risk factor for multifactorial diseases? Curr Drug Targets 2011; 12: 97-106.
3. Holick MF., Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
4. Kamen D, Aranow C., Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008; 20: 532-7.
5. Zold E, Barta Z, Bodolay E., Vitamin D deficiency and connective tissue disease. Vitam Horm 2011; 86: 261-86.
6. Yang CY, Leung PS, Adamopoulos IE, Gershwin ME., The implication of vitamin D and autoimmunity: A comprehensive review. Clin Rev Allergy Immunol 2013; 45: 217-26.
7. Gatenby P, Lucas R, Swaminathan A., Vitamin D deficiency and risk for rheumatic diseases: An update. Curr Opin Rheumatol 2013; 25: 184-91.
8. Cutolo M, Otsa K., Vitamin D, immunity and lupus. Lupus 2008; 17: 6-10.
9. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A., Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-8.
10. Hypponen E. Vitamin D and increasing incidence of type 1 diabetes: Evidence for an association? Diabetes Obes Metab 2010; 12: 737-43.
11. Antico A, Tampoia M, Tozzoli R, Bizzaro N., Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012; 12: 127-36.
12. Mandal M, Tripathy R, Panda AK, Pattanaik SS, Dakua S, Pradhan AK, et al., Vitamin D levels in Indian systemic lupus erythematosus patients: Association with disease activity index and interferon alpha. Arthritis Res Ther 2014; 16: R49.
13. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS., Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-7.
14. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A., Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 2011; 20: 1155-60.
15. Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B., Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus [letter]. Ann Rheum Dis 2009; 68: 446-7.
16. Amital H, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, et al., Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69: 155-7.
17. Hamza RT, Awwad KS, Ali MK, Hamed AI., Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: Relation to disease activity. Med Sci Monit 2011; 17: 711-8.
18. Wysenbeek AJ, Leibovici L, Weinberger A, Guedj D., Fatigue in systemic lupus erythematosus: Prevalence and relation to disease expression. Br J Rheumatol 1993; 32: 633-5.
19. Tench CM, McCurdie I, White PD, D'Cruz DP., The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 1249-54.
20. Stockton KA, Kandiah DA, Paratz JD, Bennell KL., Fatigue, muscle strength and vitamin D status in women with systemic lupus erythematosus compared with healthy controls. Lupus 2012; 21: 271-8.
21. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C., Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008; 47: 920-3.
22. Houghton KM, Tucker LB, Potts JE, McKenzie DC., Fitness, fatigue, disease activity, and quality of life in pediatric lupus. Arthritis Rheum 2008; 59: 537-45.
23. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM., Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155: 260-5.
24. Peracchi OA, Terreri MT, Munekata RV, Len CA, Sarni RO, Lazaretti-Castro M, et al., Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus. Braz J Med Biol Res 2014; 47: 721-6.
25. Stagi S, Cavalli L, Bertini F, de Martino M, Cerinic MM, Brandi ML, et al., Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: A cross-sectional study. Lupus 2014; 23: 1059-65.
26. Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM., Juvenile onset lupus: A possible role for vitamin D in disease status and bone. Lupus 2012; 21: 1335-42.
27. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C., Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 2010; 62: 1160-5.
28. Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, et al., Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 2012; 5: R221.
29. Petri M, Bello KJ, Fang H, Magder LS., Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum 2013; 65: 1865-71.
30. Abou-Raya A, Abou-Raya S, Helmii M., The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: A randomized placebo-controlled trial. J Rheumatol 2013; 40: 265-72.
31. Hochberg MC., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
32. Fuchs SC, Guimaraes SM, Sortica C, Wainberg F, Dias KO, Ughini M, et al., Reliability of race assessment based on the race of the ascendants: A cross-sectional study. BMC Public Health 2002; 2: 1-5.
33. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
34. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al, and the European Consensus Study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research: III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 1992; 10: 549-54.
35. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD., The Fatigue Severity Scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-3.
36. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al., and the Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
37. Wortsman J, Matsuoka L, Chen T, Lu Z, Holick MF., Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-3.
38. Sahebari M, Nabavi N, Salehi M., Correlation between serum 25(OH)D values and lupus disease activity: An original article and a systematic review with meta-analysis focusing on serum VitD confounders. Lupus 2014; 23: 1164-77.
39. Chaiamnuay S, Chailurkit LO, Narongroeknawin P, Asavatanabodee P, Laohajaroensombat S, Chaiamnuay P., Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus. J Clin Rheumatol 2013; 19: 121-5.
40. Canalis E, Mazziotti G, Giustina A, Bilezikian JP., Glucocorticoid-induced osteoporosis: Pathophysiology and therapy. Osteoporos Int 2007; 18: 1319-28.
41. Arnson Y, Amital H, Shoenfeld Y., Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-42.
42. Cutolo M., Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford) 2009; 48: 210-2.
43. Schneider L, Dos Santos A, Santos M, da Silva Chakr R, Monticielo O., Vitamin D and systemic lupus erythematosus: State of the art. Clin Rheumatol 2014; 33: 1033-8.
44. Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC, et al., Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 1569-74.
45. Birmingham DJ, Hebert LA, Song H, Noonan WT, Rovin BH, Nagaraja HN, et al., Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 2012; 21: 855-64.
46. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE, and the APPLE Investigators. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med 2014; 1: E000011.
47. Kiani AN, Fang H, Magder LS, Petri M., Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford) 2013; 52: 2071-6.
48. Schmeding A, Schneider M., Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2013; 27: 363-7.